Total Funding
$25.0M
Last Round
$25.0M GrantJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

NUVISAN GmbH is a Drug Discovery company. It has raised $25.0M in total across 1 round, most recently a $25.0M Grant round in Jun 2026. Investors include Bill & Melinda Gates Foundation.

Funding History

GrantJun 2026
$25.0M

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NUVISAN GmbH on Indexed.vc
<a href="https://indexed.vc/companies/nuvisan-gmbh"><img src="https://indexed.vc/api/badge/company/nuvisan-gmbh" alt="NUVISAN GmbH on Indexed.vc" width="260" height="76" /></a>